Long-term ingestion of the drug can lead to a 'potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication.'
Long-term ingestion of the drug can lead to a "potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication."Kristoffer Tripplaar / Sipa USA via AP filePfizer is voluntarily recalling all lots of its anti-smoking drug Chantix due to high levels of cancer-causing agents called nitrosamines in the pills., the Food and Drug Administration said Thursday.
For this reason, the FDA said on Friday that patients taking the recalled drug"should continue taking their current medicine until their pharmacist provides a replacement or their doctor prescribes a different treatment." "The health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline,"Pfizer initially paused distribution of the drug in June, and has already recalled a number of lots of the medicine so far. At the time, the company said the pause in distribution was conducted out of an abundance of caution, pending further testing.
Nicole Acevedo is a reporter for NBC News Digital. She reports, writes and produces stories for NBC Latino and NBCNews.com.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer recalls all lots of anti-smoking drug over carcinogen presencePfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.
Lire la suite »
What to expect as FDA advisory panel debates Pfizer COVID booster shotsThe FDA's independent advisory committee is convening to review data submitted by Pfizer and discuss whether a booster dose is safe enough for widespread use and whether it's necessary and effective at improving protection levels against COVID-19.
Lire la suite »
FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older.
Lire la suite »
FDA Advisory Panel Rejects Widespread Pfizer Vaccine Booster ShotsThe 16-2 vote is a blow to the Biden administration's plans for giving booster shots to most Americans.
Lire la suite »
US govt advisers vote no to Pfizer Covid boosters for ages 16 and upLeading US medical experts advising the government voted against recommending booster doses of Pfizer's COVID-19 vaccine for everyone aged 16 and up, citing concerns about potential side-effects in younger age groups.
Lire la suite »